References and Notes
<A NAME="RS04407ST-1">1</A>
Katrikzy AR.
Rees CW.
Scriven EFV. In Comprehensive Heterocyclic Chemistry II
Vol. 5:
McKillop A.
Elsevier Publishing Co.;
Amsterdam:
1996.
<A NAME="RS04407ST-2">2</A>
Bukuru JF.
Van Tuyen N.
Van Puyvelde L.
Mathenge SG.
Mudida FP.
De Kimpe N.
J. Nat. Prod.
2002,
65:
783
<A NAME="RS04407ST-3">3</A>
BenliSmane AF.
Ponchus YF.
Verbist JF.
Petit J.-Y.
Brion JD.
Welin LJ.
Clin. Pharmacol.
1995,
35:
298
<A NAME="RS04407ST-4A">4a</A>
Engler TA.
LaTessa KO.
Iyengar R.
Chai WY.
Agrios K.
Bioorg. Med. Chem.
1996,
4:
1755
<A NAME="RS04407ST-4B">4b</A>
Yamagishi T.
Fujioka T.
Mihashi K.
Mizuki K.
Cosentino LM.
Fowke K.
Morris-Natschke SL.
Lee KH.
Tetrahedron
2001,
57:
1559
<A NAME="RS04407ST-5A">5a</A>
Kidwai M.
Saxena S.
Khan MKR.
Thukral SS.
Bioorg. Med. Chem. Lett.
2005,
15:
4295
<A NAME="RS04407ST-5B">5b</A>
Khafagy MM.
Abd El-Wahab AHF.
Eid FA.
El-Agrody AM.
Farmaco
2002,
57:
715
For the preparation of cordiachromene, see:
<A NAME="RS04407ST-6A">6a</A>
Bouzbouz S.
Goujon JY.
Deplanne J.
Kirschleger B.
Eur. J. Org. Chem.
2000,
3223
<A NAME="RS04407ST-6B">6b</A>
Goujon JY.
Zammattio F.
Kirschleger B.
Tetrahedron: Asymmetry
2000,
11:
2409
<A NAME="RS04407ST-6C">6c</A>
Kahn PH.
Cossy J.
Tetrahedron Lett.
1999,
40:
8113
<A NAME="RS04407ST-7">7</A>
Ferreira VF.
Pinto AV.
Coutada LCM.
Ann. Acad. Brasil. Cienc.
1980,
52:
478
<A NAME="RS04407ST-8">8</A>
Yavari I.
Ramazani A.
J. Chem. Res., Synop.
1996,
382
<A NAME="RS04407ST-9A">9a</A>
Hekmatshoar R.
Souri S.
Faridbod F.
Phosphorus, Sulfur Silicon Relat. Elem.
2003,
178:
1457
<A NAME="RS04407ST-9B">9b</A>
Nicolaides DN.
Lefkaditis DA.
Lianis PS.
Litinas KS.
J. Chem. Soc., Perkin Trans. 1
1989,
2329
<A NAME="RS04407ST-9C">9c</A>
Nicolaides DN.
Adamopoulos SG.
Hatzigrigorioub EJ.
Litinas KE.
J. Chem. Soc., Perkin Trans. 1
1991,
3159
<A NAME="RS04407ST-9D">9d</A>
Nicolaides DN.
Gautam DR.
Litinas KE.
Papamehael T.
J. Chem. Soc., Perkin Trans. 1
2002,
1455
<A NAME="RS04407ST-10A">10a</A>
Kumar P.
Bodas MS.
Org. Lett.
2000,
2:
3821
<A NAME="RS04407ST-10B">10b</A>
Nicolaides DN.
Litinas KE.
Lefkaditas DA.
Adamopoulos SG.
Raptopoulou CP.
Terzis A.
J. Chem. Soc., Perkin Trans. 1
1994,
2107
<A NAME="RS04407ST-10C">10c</A>
Nicolaides DN.
Adamopoulos SG.
Lefkaditas DA.
Litinas KE.
J. Chem. Soc., Perkin Trans. 1
1992,
2479 ; and earlier articles
<A NAME="RS04407ST-10D">10d</A>
Boulos LS.
Elrahman NMA.
Phosphorus, Sulfur Silicon Relat. Elem.
1992,
68:
241
<A NAME="RS04407ST-11">11</A>
Fieser LF.
J. Am. Chem. Soc.
1926,
48:
2922
<A NAME="RS04407ST-12A">12a</A>
Hooker SC.
J. Chem. Soc.
1892,
611
<A NAME="RS04407ST-12B">12b</A>
Pérez-Sacau E.
Estévez-Braun A.
Ravelo A.
Ferro EA.
Tokuda H.
Mukainakac T.
Nishino H.
Bioorg. Med. Chem.
2003,
11:
483
<A NAME="RS04407ST-12C">12c</A>
Pérez-Sacau E.
Estévez-Braun A.
Ravelo A.
Yapu DG.
Turba AG.
Chem. Biodivers.
2005,
2:
264
<A NAME="RS04407ST-13">13</A>
Fieser LF.
Fieser M.
J. Am. Chem. Soc.
1948,
70:
3215
<A NAME="RS04407ST-14">14</A>
Alves GBC.
Lopes RSC.
Lopes CC.
Snieckus V.
Synthesis
1999,
1875
<A NAME="RS04407ST-15">15</A>
Reibenspies JH.
Willams HJ.
Ortiz C.
Scout AI.
Suarez M.
Domínguez XA.
J. Crystallogr. Spectrosc. Res.
1989,
19:
597
<A NAME="RS04407ST-16">16</A>
Data was obtained at 120 K with Mo KGk-α radiation by means of the Enraf Nonius KappaCCD
area detector diffractometer of the EPSRC crystallographic service, based at the University
of Southampton. Data collection was carried out under the control of the program COLLECT17a and data reduction and unit cell refinement were achieved with the COLLECT17a and DENZO programs.17b Correction for absorption, by comparison of the intensities of equivalent reflections,
was applied using the program SADABS.17c The program ORTEP-3 for Windows17d was used in the preparation of Figure
[3]
and SHELXL-9717e and PLATON17f in the calculation of molecular geometry. The structure was solved by direct methods
using SHELXS-9717g and fully refined by means of the program SHELXL-97.17e In the final stages of refinement, hydrogen atoms were introduced in calculated positions
and refined with a riding model.
<A NAME="RS04407ST-17A">17a</A>
Hooft RWW.
COLLECT
Nonius BV;
Delft / The Netherlands:
1998.
<A NAME="RS04407ST-17B">17b</A>
Otwinowski Z.
Minor W.
Methods in Enzymology, Macromolecular Crystallography, Part A
Vol. 276:
Carter CW.
Sweet RM.
Academic Press;
New York:
1997.
p.307
<A NAME="RS04407ST-17C">17c</A>
Sheldrick GM.
SADABS, Version 2.10.
Bruker AXS Inc.;
Madison / Wisconsin / USA:
2003.
<A NAME="RS04407ST-17D">17d</A>
Farrugia LJ.
J. Appl. Crystallogr.
1999,
32:
837
<A NAME="RS04407ST-17E">17e</A>
Sheldrick GM.
SHELXL-97: Program for Crystal Structure Refinement
University of Göttingen;
Germany:
1997.
<A NAME="RS04407ST-17F">17f</A>
Spek AL.
J. Appl. Crystallogr.
2003,
36:
7
<A NAME="RS04407ST-17G">17g</A>
Sheldrick GM.
SHELXS-97: Program for the Solution of Crystal Structures
University of Göttingen;
Germany:
1997.
<A NAME="RS04407ST-18">18</A>
Crystal data collected at 120 K, colourless crystal: 0.16 × 0.10 × 0.06 mm3. Formula: C20H22O2; M = 294.38; monoclinic, P21/c, a = 8.657(2) Å, b = 7.9525(17) Å, c = 23.385(6) Å, β = 92.815(9)°, Z = 4, V = 1608.0(7) Å3, 3696 independent reflections [R(int) = 0.1482], 1562 observed reflections [I >2s(I)]; parameters refined: 203; number
of restraints: 0; R(F): 0.1839 (obs. data), Δρmax = 0.28 Å-3. CCDC deposition no: 292382.
<A NAME="RS04407ST-19A">19a</A>
Li CJ.
Wang C.
Pardee BA.
Cancer Res.
1995,
55:
3712
<A NAME="RS04407ST-19B">19b</A>
Pardee AB.
Li YZ.
Li CJ.
Curr. Cancer Drug Targets
2002,
2:
227
<A NAME="RS04407ST-19C">19c</A>
Huang LL.
Pardee AB.
Mol. Med.
1999,
5:
711
<A NAME="RS04407ST-19D">19d</A>
Li CJ.
Averboukh L.
Pardee AB.
J. Biol. Chem.
1993,
268:
22463
<A NAME="RS04407ST-19E">19e</A>
Frydman B.
Marton LJ.
Sun SJ.
Neder K.
Witiak TD.
Liu AA.
Wang HM.
Mao Y.
Wu HY.
Sanders MM.
Liu LF.
Cancer Res.
1997,
57:
620
<A NAME="RS04407ST-19F">19f</A>
Li CJ.
Li Y.-Z.
Pinto AV.
Pardee AB.
Proc. Natl. Acad. Sci. U.S.A.
1999,
96:
13369
<A NAME="RS04407ST-20A">20a</A>
da Silva MN.
Ferreira VF.
de Souza MCBV.
Quim. Nova
2003,
26:
407
<A NAME="RS04407ST-20B">20b</A>
Dubin M.
Fernadez-Villamil SH.
Stoppani AO.
Medicina
2001,
61:
343
<A NAME="RS04407ST-21A">21a</A>
Ferreira VF.
Jorqueira A.
Souza AMT.
da Silva MN.
de Souza MCBV.
Gouvêa RM.
Rodrigues CR.
Pinto AV.
Castro HC.
Santos DO.
Araújo HP.
Bourguignon SC.
Bioorg. Med. Chem.
2006,
14:
5459
<A NAME="RS04407ST-21B">21b</A>
Barbosa TP.
Camara CA.
Silva TMS.
Martins RM.
Pinto AV.
Vargas MD.
Bioorg. Med. Chem.
2005,
13:
6464
<A NAME="RS04407ST-21C">21c</A>
Silva TMS.
Camara CA.
Barbosa TP.
Soares AZ.
da Cunha LC.
Pinto AV.
Vargas MD.
Bioorg. Med. Chem.
2005,
13:
193
<A NAME="RS04407ST-21D">21d</A>
de Moura KCG.
Salomão K.
Menna-Barreto RFS.
Emery FS.
Pinto MCFR.
Pinto AV.
Castro SL.
Eur. J. Med. Chem.
2004,
39:
639
<A NAME="RS04407ST-22">22</A>
General Procedure for 2
H
-Chromenes 7-10: A mixture of the naphthoquinone (0.02 mol), allyltriphenylphosphonium salt (0.04
mol), CHCl3 (15 mL) and aq 50% NaOH (15 mL, 0.19 mol) was vigorously stirred for 48 h at r.t.
The organic phase was collected, washed with H2O (3 × 10 mL), dried over MgSO4 and the solvent was evaporated. Purification of the crude product was achieved by
flash column chromatography using hexane-CH2Cl2 as eluent.
6-Methoxy-3,3-dimethyl-3
H
-benzo[
f
]chromene (7a): IR (KBr): 2971, 2938, 1634, 1588, 1574, 1515, 1464, 1450, 1443, 1411, 1379, 1351,
1283, 1247, 1220, 1207, 1199, 1160, 1130, 1119, 1092, 996, 981, 885, 841, 755, 727,
694, 626 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.50 (s, 6 H, Me), 3.98 (s, 3 H, OMe), 5.58 (d, J = 9.8 Hz, 1 H, H-2), 6.48 (s, 1 H, H-5), 6.95 (d, J = 9.8 Hz, 1 H, H-1), 7.30 (ddd, J = 1.2, 6.8, 8.5 Hz, 1 H, H-8), 7.49 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-9), 7.89 (ddd, J = 0.7, 1.2, 8.3 Hz, 1 H, H-7), 8.17 (ddd, J = 0.7, 1.2, 8.5 Hz, 1 H, H-10). 13C NMR (75.0 MHz, CDCl3): δ = 27.4 (Me), 27.4 (Me), 55.5 (OMe), 76.2 (C-3), 97.4 (C-5), 106.8 (C-10b), 118.1
(C-1), 120.9 (C-10), 121.3 (C-6a), 122.3 (C-7), 122.5 (C-8), 126.0 (C-2), 127.1 (C-9),
130.4 (C-10a), 151.6 (C-4a), 156.4 (C-6). EIMS: m/z (%) = 240 (22) [M+], 225 (100), 210 (15). HRMS: m/z calcd for C16H16O2: 240.1150; found: 240.1139.
2,2,6,6-Tetramethyl-3,4-dihydro-2
H
,6
H
-1,5-dioxatri-phenylene (8a): mp 89-90 °C. IR (KBr): 2975, 2934, 1637, 1578, 1510, 1465, 1453, 1428, 1418, 1396,
1383, 1369, 1360, 1325, 1289, 1253, 1237, 1220, 1195, 1159, 1137, 1119, 1003, 974,
881, 762, 732, 710, 691, 665, 646 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.41 (s, 6 H, Me), 1.47 (s, 6 H, Me), 1.86 (t, J = 6.8 Hz, 2 H, H-3), 2.77 (t, J = 6.8 Hz, 2 H, H-4), 5.54 (d, J = 10.0 Hz, 1 H, H-7), 6.95 (d, J = 10.0 Hz, 1 H, H-8), 7.27 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-11), 7.41 (ddd, J = 1.2, 6.8, 8.3 Hz, 1 H, H-10), 7.85 (ddd, J = 0.5, 1.2, 8.3 Hz, 1 H, H-12), 8.14 (ddd, J = 0.5, 1.2, 8.3 Hz, 1 H, H-9). 13C NMR (75 MHz, CDCl3): δ = 19.9 (C-4), 29.3 (Me), 29.3 (Me), 78.6 (C-6), 34.7 (C-3), 77.1 (C-2), 78.6
(C-6), 106.6 (C-8a), 110.3 (C-4a), 121.2 (C-9), 123.3 (C-12), 123.6 (C-12a), 124.6
(C-11), 124.8 (C-8), 128.0 (C-7), 128.7 (C-10), 131.6 (C-8b), 152.5 (C-4b), 152.6
(C-13). EIMS: m/z (%) = 294 (44) [M+], 279 (77), 223 (100). HRMS: m/z calcd for C20H22O2: 294.1620; found: 294.1617.
5,6,7,8-Tetrachloro-2,2-dimethyl-2
H
-chromene (10): yellow solid; mp 83-84 °C. IR (KBr): 2924, 2870, 2854, 1681, 1600, 1455, 1428, 1392,
1379, 1327, 1308, 1237, 1225, 1205, 1151, 1051, 1018, 996, 970, 924, 900, 834, 791,
663 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.87 (d, J = 1.5 Hz, 3 H, Me), 1.88 (d, J = 1.5 Hz, 3 H, Me), 5.55 (dsept, J = 1.5, 8.3 Hz, 1 H, H-2), 6.92 (d, J = 8.3 Hz, 1 H, H-1). 13C NMR (75 MHz, CDCl3): δ = 19.0 (Me), 26.4 (Me), 30.0 (C-3), 111.0 (C-1), 112.9 (C-5), 118.3 (C-2), 125.1
(C-8a), 126.0 (C-7), 128.0 (C-6), 144.9 (C-8), 146.7 (C-4a).